|
The Effects of Biology
and Environment on Brain Development
Andrea Sherbondy, MD, Assistant Professor, Clinical Pediatrics,
Don Van Dyke, MD, Associate Professor, Pediatrics
Spring 1998.
Understanding the processes of normal brain development is a prerequisite for
understanding the influences of biological and environmental factors. At certain
stages in development, certain brain structures may be more vulnerable than
others to these factors. Research into these factors and their pathogenic mechanisms
is a crucial first step in designing interventions to prevent brain damage and
promote normal brain development.
Biology and brain development
.
Genes play a major role in how the brain develops during the prenatal period
and the first few months after birth. Scientists believe that one-half the entire
human genome may be dedicated to the formation of the brain, which begins as
a simple layer of cells and eventually includes as many as 10 billion brain
cells called neurons, as well as billions of neuronal connections called synapses.
Brain development occurs in overlapping phases. The first step is the formation
of the primitive nervous system, the neural tube (NT). Closure of the NT takes
place when the fetus is 21 to 26 days old. Neurons, which start to form before
the neural tube closes and continue to form during the first year of life, differentiate
according to structure and function. The large motor neurons form first, then
the sensory neurons. Structures with complex layers of cells that are key to
brain function, such as the cerebral cortex, hippocampus, and cerebellum, will
add cells over a long period. The brain stem and diencephalon form early; the
hippocampus, which serves memory function, is the only part of the brain in
which neuron growth may continue into adulthood.
|
As cells important for brain structure increase in number, certain
new cells migrate from their point of origin to their final position
in the central nervous system. Most migration occurs early in gestation.
Migration of cells to such areas as the cerebral cortex, hippocampus
and cerebellum may continue for several months after birth. Many neurons
(illustrated at right) must be in their proper locations to function
normally.
|

|
Other facets of early brain development include:
- Extending neuritic processes.
- Forming synapses.
- Developing cell receptors to bind chemical neurotransmitters.
- Trimming excess synapses .
- Coating axons with myelin, which speeds transmissions along neurons.
Interaction with the environment stimulates the creation of neural circuits
-- the functional units of mental activity. In the newborn period, the brain
also begins a pruning process to get rid of excess neurons and neuronal connections,
and about half of the synapses present at age two years are eventually trimmed
back. Usually this trimming removes unused neural connections..
|

|
Genetic disorders
Down syndrome. Children born with chromosomal abnormalities
frequently demonstrate anatomical differences, mental retardation, and
deficits in brain function. One of the most common chromosomal abnormalities
is Down syndrome, in which children most frequently have an extra chromosome
21 (trisomy 21).
|
Fragile X syndrome. Fragile X syndrome, the leading known
cause of inherited mental retardation, occurs in approximately 1:1,200 males
and 1:2,500 females. This syndrome is caused by a mutation in the FMR1 gene,
located on the long arm of the X chromosome. The FMR1 gene codes for a protein
whose exact function is an area of active investigation. Similar proteins often
act on genes responsible for neuron function and migration. Individuals with
fragile X syndrome, particularly males, show a significant degree of neuropsychological
and communication dysfunction.
Rett syndrome. Rett syndrome (RS), a genetically determined
disorder, primarily affects brain growth in girls. Early development may be
normal, followed by a period of regression with the loss of acquired hand use
and speech by 3 years of age, precursors to severe mental retardation. Brain
size and weight are markedly reduced from normal.
Autism. We do not know the causes of autism; it appears to
have multiple etiologies. The prevalence of autism is 4 to 5 per 10,000; its
milder manifestation, pervasive developmental disorder (PDD), has a prevalence
of about 8 to 10 per 10,000. MRI, CT, and PET imaging studies are being used
to investigate anatomical and metabolic differences in autism; new research
is looking at the immune system, embryology, and teratology.
Primary brain malformations. A number of major malformations
of the brain are seen in isolation, as well as with known genetic and chromosomal
syndromes. The causes are probably multiple and overlapping. Recent research
in molecular genetics has focused on looking for genetic markers associated
with malformations.
Environment and brain development
Maternal health.
Diabetes. Insulin-dependent diabetes mellitus poses a risk
to the unborn child, and this risk may be increased if the diabetes is poorly
controlled. The most common birth defects associated with diabetes include neural
tube defects, other CNS defects, and congenital heart disease. Prevention is
the best treatment; infants born to women whose diabetes is well-controlled
during the first trimester appear to have a decreased risk of birth defects
when compared to infants born to mothers whose diabetes is poorly controlled.
Epilepsy. Maternal epilepsy is associated with a two- to threefold
increase in birth defects. Fetal exposure to the anticonvulsants phenytoin and
other hydantoins can cause fetal hydantoin syndrome (30% of exposed fetuses
have anomalies; 10%,full syndrome). The anticonvulsant valproic acid has been
associated with an increase in spina bifida; fetal carbamazepine exposure has
also been implicated as a possible cause of increased rates of spina bifida.
Hypoxia/ischemia. If a pregnant woman is oxygen-deprived for
a significant time, or if the fetus is oxygen-starved for other reasons, damage
to the brain of the unborn child can occur. Certain cells in the developing
brain are more vulnerable to damage resulting from poor blood perfusion and
low oxygen levels. Much of the damage appears to occur during the reoxygenation-reperfusion
phase. Current research on the mechanisms of injury includes investigation of
cell metabolism, enzyme activation, oxygen free radicals, and gene expression.
Infection. The developing nervous system of the fetus is particularly
sensitive to damage from a group of maternal infections known as TORCH
infections: Toxoplasmosis, other (arbovirus,
Coxsackie, mumps, HIV, mumps, parvovirus, varicella, syphilis), rubella
(German measles), cytomegalovirus, and herpes.
PKU. If a woman with PKU is not on a low phenylalanine diet
during her pregnancy, there is a 90% chance that her child will be born with
mental retardation due to fetal intrauterine exposure to high levels of phenylalanine.
The best way to prevent this is for the mother to observe a strict, low phenylalanine
diet prior to as well as during pregnancy.
Environmental toxins .
How environmental toxins affect the brain depends on developmental phase and
the level of sensitivity in different regions of the brain. Ionizing radiation,
such as x-rays or gamma rays, kill neurons that are being actively produced,
but may have no impact on neurons made either before or after the exposure.
Methylmercury, a toxic heavy metal, has the same effect. Because neurons usually
are not replaced, cell loss is permanent. The loss of neurons can also interfere
with normal neuronal cell migration.
Toxins like lead, and conditions like malnutrition and hypothyroidism (low
thyroid hormone levels), interfere with the development of synapses. Although
new synapses can be made, interference with their development can block neurotransmitter
signals at important stages in brain growth, and thus interfere with brain development.
Pesticide and herbicide exposure are also thought to interfere with synapse
formation and function.
Medications. Current research reports that the average pregnant
woman takes from 4 to 9 different medications during her pregnancy. While only
a small number of medications have been identified as definitely teratogenic
-- harmful to the fetus -- in humans, many drugs have never been tested. Some
known teratogens are described below; for more information, see
"Teratogens that Can Affect Brain Development."
Substance abuse .
Alcohol. Alcohol is a known teratogen that has adverse effects
on the development of multiple organ systems of the developing fetus, effects
that persist throughout the individual's life. Autopsies of individuals with
fetal alcohol syndrome (FAS) show such abnormalities as smaller than normal
brain size and a deficit of neurons. The range of malformations suggests that
alcohol may cause damage via multiple mechanisms.
Cocaine. The recreational use of cocaine may also cause harm
to the developing fetus. Infants born to women who abuse cocaine have had such
brain abnormalities as cerebral infarction (stroke) and porencephaly.
Toluene. Solvent abuse -- the "sniffing" of glue,
paint, etc. -- is a practice followed by an estimated 3 to 4% of teenagers and
young adults. Early research suggests that women who abuse solvents during pregnancy
may bear children with abnormalities similar to those found in FAS.
Promoting optimal development .
Folic acid. Failure of neural tube closure produces neural
tube defects (NTDs), most commonly anencephaly (absence of most of the brain)
and spina bifida (a defect of the spine and spinal cord). Dietary supplementation
with folic acid may prevent from 50% to 70% of this birth defect, but the mechanism
is poorly understood. Because the neural tube closes by the 29th
day after conception, folic acid is maximally effective if a woman begins taking
it at least one month before conception occurs. The required dose, 0.4 mg per
day, is found in many over-the-counter multivitamins. For women who have already
had an affected pregnancy, the dose is higher: 4.0 mg per day. It is very important
for women who take anticonvulsant medication to talk with their physicians about
taking folic acid.
Breast feeding. Recent studies show benefits in cognitive
development when infants are breast fed, and a look at the structure of the
brain helps to explain why. Approximately 60% of the material that makes up
the brain is composed of lipids, a fatty material. Long-chain polyunsaturated
fatty acids (LCPs) are an important component of lipids. Preliminary studies
suggest that LCPs present in breast milk may play a critical role in the development
of vision in newborns, and may contribute as well to cortical function and intellectual
development. Certain fatty acids derived from LCPs may be absent or in short
supply in certain formulas.
|
|
Guiding young mothers
.
Currently, the best strategies for promoting optimal brain development
include the provision of guidance to young women about
- Family planning, with guidance on adequate maternal nutrition and
folic acid supplementation..
- The effects of medications, illicit drugs, glue sniffing, smoking,
and alcohol use on the unborn child..
- Adequate maternal pre- and perinatal health care, to provide maternal
immunization against rubella and varicella, promote healthy pregnancies,
and prevent or treat infection. .
- Avoidance of maternal exposure to toxic materials..
- Parenting, including breastfeeding, and the provision of developmentally
appropriate stimulation, such as reading, even to very young children.
|
In conclusion, genetic influences play a substantial role
in brain development. The high sensitivity of the brain to environmental influences
during fetal and postnatal life is likewise a crucial factor. Every day, research
into the molecular genetics, anatomy, and physiology of the brain adds to our
understanding of how it functions; from this work will come new insights into
how we, as health care providers, can best foster optimal brain development.
Resources:
- Longo, Lawrence and Sayseelan Packianathan. Hypoxia-ischaemia and the developing
brain: hypotheses regarding the pathophysiology of fetal-neonatal brain damage.
British J Obstetrics & Gyn, 6-1997, v.104:652-662. .
- Rodier, P.M. Developing brain as a target of toxicity. Environmental
Health Perspectives, 9-1995, v.103, suppl. 6: 73-76 .
|